1 unchanged sentence
From time to time, the Company issues shares of common stock in reliance on the private placement exemption under Section 4(a)(2) of the Securities Act of 1933, as amended, in exchange for Omega OP Units.
−Removed: During the quarter ended S eptember 30, 2023, Omega did not issue any shares of our common stock in exchange for Omega OP Units.
+Added: During the quarter ended March 31, 2024, Omega issued an aggregate of 10,838 shares of Omega common stock in exchange for an equivalent number of Omega OP Units tendered to Omega OP for redemption in accordance with the provisions of the partnership agreement governing Omega OP in reliance on this exemption.
Issuer Purchases of Equity Securities
−Removed: On January 27, 2022, the Board of Directors authorized the Company to repurchase of up to $500 million of our outstanding common stock from time to time through March 2025.
+Added: On January 27, 2022, the Board of Directors authorized the Company to repurchase up to $500 million of its outstanding common stock from time to time through March 2025.
The Company is authorized to repurchase shares of its common stock in open market and privately negotiated transactions or in any other manner as determined by the Company’s management and in accordance with applicable law.
1 unchanged sentence
The Company has no obligation to repurchase any amount of its common stock, and such repurchases, if any, may be discontinued at any time.
−Removed: During the third quarter of 2023, we did not repurchase any shares of our outstanding common stock.
−Removed: Item 6–Exhibits
−Removed: Credit Agreement, dated as of August 8, 2023, among Omega Healthcare Investors, Inc., certain subsidiaries of Omega Healthcare Investors, Inc.
−Removed: identified therein as guarantors, the lenders named therein and Bank of America, N.A., as administrative agent for such lenders (Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed August 11, 2023).
−Removed: Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer of Omega Healthcare Investors, Inc.*
−Removed: Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer of Omega Healthcare Investors, Inc.*
−Removed: Section 1350 Certification of the Chief Executive Officer of Omega Healthcare Investors, Inc.*
−Removed: Section 1350 Certification of the Chief Financial Officer of Omega Healthcare Investors, Inc.*
−Removed: The following financial statements (unaudited) from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023, formatted in Inline XBRL:
−Removed: (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Comprehensive Income, (iv) Consolidated Statements of Equity, (v) Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags.
−Removed: Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document (included in Exhibit 101).
−Removed: * Exhibits that are filed herewith.
−Removed: Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: OMEGA HEALTHCARE INVESTORS, INC.
−Removed: November 3, 2023
−Removed: TAYLOR PICKETT
−Removed: Taylor Pickett
−Removed: Chief Executive Officer
−Removed: November 3, 2023
−Removed: /S/ ROBERT O.
−Removed: Chief Financial Officer
+Added: During the first quarter of 2024, we did not repurchase any shares of our outstanding common stock.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.